Citations (91)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Pauliina Molander, Helena Kemppainen, Tuire Ilus & Taina Sipponen. (2020) Long-term deep remission during maintenance therapy with biological agents in inflammatory bowel diseases. Scandinavian Journal of Gastroenterology 55:1, pages 34-40.
Read now
Read now
João Batista Tajra, José Ulisses Calegaro, Ana Patrícia de Paula, Dunya Bachour, Dannilo Silveira, Mariela Lozi & Hugo Cavalcanti. (2019) Correlation and concordance measures between clinical, endoscopic and histological scores activity in Crohn’s disease under treatment. Scandinavian Journal of Gastroenterology 54:4, pages 441-445.
Read now
Read now
Samuele Naviglio, Paolo Giuffrida, Gabriele Stocco, Marco Vincenzo Lenti, Alessandro Ventura, Gino Roberto Corazza & Antonio Di Sabatino. (2018) How to predict response to anti-tumour necrosis factor agents in inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology 12:8, pages 797-810.
Read now
Read now
Magali de Bruyn, Jennifer Vandooren, Estefania Ugarte-Berzal, Ingrid Arijs, Séverine Vermeire & Ghislain Opdenakker. (2016) The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases. Critical Reviews in Biochemistry and Molecular Biology 51:5, pages 295-358.
Read now
Read now
Monia Marchetti & Nicola Lucio Liberato. (2014) Biological therapies in Crohn’s disease: are they cost-effective? A critical appraisal of model-based analyses. Expert Review of Pharmacoeconomics & Outcomes Research 14:6, pages 815-824.
Read now
Read now
Sunanda V. Kane, Srihari Jaganathan, Angela V. Bedenbaugh, Liisa Palmer & David A. Schwartz. (2014) Anti-tumor necrosis factor agents reduce corticosteroid use compared with azathioprine in patients with Crohn’s disease. Current Medical Research and Opinion 30:9, pages 1821-1826.
Read now
Read now
C Janneke van der Woude & Daniel W Hommes. (2007) Biologics in Crohn's disease: searching indicators for outcome. Expert Opinion on Biological Therapy 7:8, pages 1233-1243.
Read now
Read now
Jane Zochling & Jürgen Braun. (2006) Developments and current pharmacotherapeutic recommendations for ankylosing spondylitis. Expert Opinion on Pharmacotherapy 7:7, pages 869-883.
Read now
Read now
Articles from other publishers (83)
Xiaolin Hu, Jiajia Li, Yunyun Sun, Dacheng Wu, Tiantian Zhao, Maofeng Ma, Jie Chen, Mei Wang & Sicong Hou. (2023) Combined use of CDAI and blood indices for assessing endoscopic activity in ileocolic Crohn’s disease. BMC Gastroenterology 23:1.
Crossref
Crossref
Roger Feakins, Paula Borralho Nunes, Ann Driessen, Ilyssa O Gordon, Nina Zidar, Pamela Baldin, Britt Christensen, Silvio Danese, Naoimh Herlihy, Marietta Iacucci, Maurice B Loughrey, Fernando Magro, Aart Mookhoek, Magali Svrcek & Francesca Rosini. (2023) Definitions of Histological Abnormalities in Inflammatory Bowel Disease: an ECCO Position Paper. Journal of Crohn's and Colitis.
Crossref
Crossref
Joana Roseira, Mafalda Santiago, Maria Manuela Estevinho, Paula Moreira, Catarina Alves, Silvio Danese, Laurent Peyrin-Biroulet, Axel Dignass, Roger Feakins & Fernando Magro. (2023) Impact of Crohn’s Disease Therapies on Histology in Randomized Controlled Trials: Systematic Review With Meta-analysis. Inflammatory Bowel Diseases 29:8, pages 1231-1243.
Crossref
Crossref
Sudheer K Vuyyuru, Tran M Nguyen, Malcolm Hogan, Tim Raine, Nurulamin M Noor, Neeraj Narula, Bram Verstockt, Brian G Feagan, Siddharth Singh, Christopher Ma & Vipul Jairath. (2023) Endoscopic and Histological Placebo Rates in Crohn’s Disease Clinical Trials: A Systematic Review and Meta-analysis. Inflammatory Bowel Diseases.
Crossref
Crossref
Anna-Maria Globig, Lena Sophie Mayer, Maximilian Heeg, Geoffroy Andrieux, Manching Ku, Patricia Otto-Mora, Anna Veronika Hipp, Katharina Zoldan, Ajinkya Pattekar, Nisha Rana, Christoph Schell, Melanie Boerries, Maike Hofmann, Christoph Neumann-Haefelin, Armin Kuellmer, Arthur Schmidt, Tobias Boettler, Vesselin Tomov, Robert Thimme, Peter Hasselblatt & Bertram Bengsch. (2022) Exhaustion of CD39-Expressing CD8+ T Cells in Crohn’s Disease Is Linked to Clinical Outcome. Gastroenterology 163:4, pages 965-981.e31.
Crossref
Crossref
Marion Lirsac, Amélie Biron, Zoubir Djerada, Guillaume Cadiot, Elise Morcos-Sauvain, Hedia Brixi, Margaux Le Saint, Aude Marchal & Camille Boulagnon-Rombi. (2022) Histological Indices and Risk of Recurrence in Crohn’s Disease: A Retrospective Study of a Cohort of Patients in Endoscopic Remission. Inflammatory Bowel Diseases 28:9, pages 1395-1404.
Crossref
Crossref
F Magro, J Sabino, F Rosini, M Tripathi, P Borralho, P Baldin, S Danese, A Driessen, I O Gordon, M Iacucci, N Noor, M Svrcek, L Peyrin-Biroulet & R Feakins. (2022) ECCO Position on Harmonisation of Crohn’s Disease Mucosal Histopathology. Journal of Crohn's and Colitis 16:6, pages 876-883.
Crossref
Crossref
Omeed Alipour, Alakh Gualti, Ling Shao & Bing Zhang. (2021) Systematic review and meta-analysis: real-world data rates of deep remission with anti-TNFα in inflammatory bowel disease. BMC Gastroenterology 21:1.
Crossref
Crossref
Roos E. Pouw, Raf Bisschops, Krisztina B. Gecse, Gert de Hertogh, Marietta Iacucci, Matthew Rutter, Maximilien Barret, Katharina Biermann, László Czakó, Tomas Hucl, Marnix Jansen, Edoardo Savarino, Manon C. W. Spaander, Peter T. Schmidt, Mário Dinis-Ribeiro, Michael Vieth & Jeanin E. van Hooft. (2021) Endoscopic tissue sampling – Part 2: Lower gastrointestinal tract. European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 53:12, pages 1261-1273.
Crossref
Crossref
Akihiro Yamada, Yuga Komaki, Fukiko Komaki, Haider Haider, Dejan Micic, Joel Pekow, Sushila Dalal, Russell D. Cohen, Lisa Cannon, Konstantin Umanskiy, Radhika Smith, Benjamin D. Shogan, Roger Hurst, Neil Hyman, David T. Rubin & Atsushi Sakuraba. (2021) The Correlation between Vitamin D Levels and the Risk of Postoperative Recurrence in Crohn’s Disease. Digestion 102:5, pages 767-775.
Crossref
Crossref
Benedetto Neri, Michelangela Mossa, Ludovica Scucchi, Giorgia Sena, Giampiero Palmieri & Livia Biancone. (2021) Histological scores in inflammatory bowel disease. Journal of Digestive Diseases 22:1, pages 9-22.
Crossref
Crossref
Jakob Benedict Seidelin, Martin Iain Bahl, Tine Rask Licht, Benjamin E. Mead, Jeffrey M. Karp, Jens Vilstrup Johansen, Lene Buhl Riis, Marina Ramírez Galera, Anders Woetmann & Jacob Tveiten Bjerrum. (2021) Acute Experimental Barrier Injury Triggers Ulcerative Colitis–Specific Innate Hyperresponsiveness and Ulcerative Colitis–Type Microbiome Changes in Humans. Cellular and Molecular Gastroenterology and Hepatology 12:4, pages 1281-1296.
Crossref
Crossref
Bruno Lima Rodrigues, Márcia Carolina Mazzaro, Cristiane Kibune Nagasako, Maria de Lourdes Setsuko Ayrizono, João José Fagundes & Raquel Franco Leal. (2020) Assessment of disease activity in inflammatory bowel diseases: Non-invasive biomarkers and endoscopic scores. World Journal of Gastrointestinal Endoscopy 12:12, pages 504-520.
Crossref
Crossref
Bing Zhang, Alakh Gulati, Omeed Alipour & Ling Shao. (2020) Relapse From Deep Remission After Therapeutic De-escalation in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Journal of Crohn's and Colitis 14:10, pages 1413-1423.
Crossref
Crossref
Britt Christensen, Jonathan Erlich, Peter R. Gibson, Jerrold R. Turner, John Hart & David T. Rubin. (2020) Histologic Healing Is More Strongly Associated with Clinical Outcomes in Ileal Crohn’s Disease than Endoscopic Healing. Clinical Gastroenterology and Hepatology 18:11, pages 2518-2525.e1.
Crossref
Crossref
Cong Dai, Min Jiang, Ming-Jun Sun & Qin Cao. (2020) Fecal Lactoferrin for Assessment of Inflammatory Bowel Disease Activity. Journal of Clinical Gastroenterology 54:6, pages 545-553.
Crossref
Crossref
Jacqueline Jossen, Bridget D. Kiernan, Nanci Pittman & Marla C. Dubinsky. (2020) Anti-tumor Necrosis Factor-alpha Exposure Impacts Vedolizumab Mucosal Healing Rates in Pediatric Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology & Nutrition 70:3, pages 304-309.
Crossref
Crossref
Chanqing Ma & Xiuli Liu. 2020. Atlas of Endoscopy Imaging in Inflammatory Bowel Disease. Atlas of Endoscopy Imaging in Inflammatory Bowel Disease
221
233
.
Katherine Li, Joshua R. Friedman, Daphne Chan, Paul Pollack, Feifei Yang, Douglas Jacobstein, Carrie Brodmerkel, Christopher Gasink, Brian G. Feagan, William J. Sandborn, Paul Rutgeerts & Gert De Hertogh. (2019) Effects of Ustekinumab on Histologic Disease Activity in Patients With Crohn’s Disease. Gastroenterology 157:4, pages 1019-1031.e7.
Crossref
Crossref
Wenbin Gong, Kun Guo, Tao Zheng, Miao Fang, Haohao Xie, Weijie Li, Zhiwu Hong, Huajian Ren, Guosheng Gu, Gefei Wang, Xiuwen Wu, Zhiming Wang, Jianan Ren & Jieshou Li. (2019) Correlation between endoscopic and histological validated scoring indices in Crohn’s disease. Digestive and Liver Disease 51:6, pages 812-817.
Crossref
Crossref
Lara Hart & Talat Bessissow. (2019) Endoscopic scoring systems for the evaluation and monitoring of disease activity in Crohn's disease. Best Practice & Research Clinical Gastroenterology 38-39, pages 101616.
Crossref
Crossref
Rish K. Pai & Vipul Jairath. (2019) What is the role of histopathology in the evaluation of disease activity in Crohn's disease?. Best Practice & Research Clinical Gastroenterology 38-39, pages 101601.
Crossref
Crossref
Anna M. Buchner & Gary R. Lichtenstein. 2019. Clinical Gastrointestinal Endoscopy. Clinical Gastrointestinal Endoscopy
425
434.e2
.
Lizhi Zhang & Tsung-Teh Wu. 2019. Surgical Pathology of Non-neoplastic Gastrointestinal Diseases. Surgical Pathology of Non-neoplastic Gastrointestinal Diseases
373
424
.
Henrike Lenzen, Jiajie Qian, Michael P Manns, Ursula Seidler & Anne Jörns. (2018) Restoration of mucosal integrity and epithelial transport function by concomitant anti-TNFα treatment in chronic DSS-induced colitis. Journal of Molecular Medicine 96:8, pages 831-843.
Crossref
Crossref
Akihiro Yamada, Yuga Komaki, Nayan Patel, Fukiko Komaki, Joel Pekow, Sushila Dalal, Russell D Cohen, Lisa Cannon, Konstantin Umanskiy, Radhika Smith, Roger Hurst, Neil Hyman, David T Rubin & Atsushi Sakuraba. (2018) The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn’s Disease. Inflammatory Bowel Diseases 24:3, pages 502-509.
Crossref
Crossref
Rish K. Pai & Karel Geboes. (2017) Disease activity and mucosal healing in inflammatory bowel disease: a new role for histopathology?. Virchows Archiv 472:1, pages 99-110.
Crossref
Crossref
Gregor Novak, Claire E Parker, Rish K Pai, John K MacDonald, Brian G Feagan, William J Sandborn, Geert D'Haens, Vipul Jairath & Reena Khanna. (2017) Histologic scoring indices for evaluation of disease activity in Crohn’s disease. Cochrane Database of Systematic Reviews 2017:7.
Crossref
Crossref
Amanda Ricciuto, Peter Church, Michael J Stewart, Hang Hock Shim, Martin Storr, Anne Marie Griffiths & Cynthia H Seow. (2017) Biological interventions for maintenance of mucosal healing in Crohn’s disease. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Amanda Ricciuto, Peter Church, Michael J Stewart, Hang Hock Shim, Martin Storr, Anne Marie Griffiths & Cynthia H Seow. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Ondrej Fabian, Ondrej Hradsky, Kristyna Potuznikova, Alena Kalfusova, Lenka Krskova, Ludmila Hornofova, Josef Zamecnik & Jiri Bronsky. (2017) Low predictive value of histopathological scoring system for complications development in children with Crohn?s disease. Pathology - Research and Practice 213:4, pages 353-358.
Crossref
Crossref
Carole Rouiller-Braunschweig, Nicolas Fournier, Valérie Pittet, Jean Dudler & Pierre Michetti. (2017) Efficacy, Safety and Mucosal Healing of Methotrexate in a Large Longitudinal Cohort of Inflammatory Bowel Disease Patients. Digestion 96:4, pages 220-227.
Crossref
Crossref
Christine Y. Yu & Daniel W. Hommes. 2017. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis
481
489
.
Francesca Palone, Roberta Vitali, Salvatore Cucchiara, Maurizio Mennini, Alessandro Armuzzi, Daniela Pugliese, Renata DʼIncà, Brigida Barberio & Laura Stronati. (2016) Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission. Inflammatory Bowel Diseases 22:12, pages 2886-2893.
Crossref
Crossref
Alissa J. Walsh, Robert V. Bryant & Simon P. L. Travis. (2016) Current best practice for disease activity assessment in IBD. Nature Reviews Gastroenterology & Hepatology 13:10, pages 567-579.
Crossref
Crossref
Anna M. Buchner & Gary R. Lichtenstein. (2016) How to Assess and Document Endoscopies in IBD Patients by Including Standard Scoring Systems. Inflammatory Bowel Diseases 22:4, pages 1010-1019.
Crossref
Crossref
S. C. Shah, J.-F. Colombel, B. E. Sands & N. Narula. (2016) Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease. Alimentary Pharmacology & Therapeutics 43:3, pages 317-333.
Crossref
Crossref
Magali de Bruyn, Ingrid Arijs, Gert De Hertogh, Marc Ferrante, Gert Van Assche, Paul Rutgeerts, Séverine Vermeire & Ghislain Opdenakker. (2015) Serum Neutrophil Gelatinase B-associated Lipocalin and Matrix Metalloproteinase-9 Complex as a Surrogate Marker for Mucosal Healing in Patients with Crohn’s Disease. Journal of Crohn's and Colitis 9:12, pages 1079-1087.
Crossref
Crossref
Ibrahim K. Onal, Yavuz Beyazit, Akif Altinbas, Mevlut Kurt & Mehmet Arhan. (2015) Maintenance therapy for Crohn’s disease. European Journal of Gastroenterology & Hepatology 27:10, pages 1115-1125.
Crossref
Crossref
Elee Shimshoni, Doron Yablecovitch, Liran Baram, Iris Dotan & Irit Sagi. (2015) ECM remodelling in IBD: innocent bystander or partner in crime? The emerging role of extracellular molecular events in sustaining intestinal inflammation. Gut 64:3, pages 367-372.
Crossref
Crossref
Paulo Gustavo Kotze, Juliano Coelho Ludvig, Fábio Vieira Teixeira, Everson Fernando Malluta, Eron Fábio Miranda, Marcelo Raisweiler Hardt, Márcia Olandoski, Lorete Maria da Silva Kotze & Harry Kleinubing, Jr.. (2015) Disease Duration Did Not Influence the Rates of Loss of Efficacy of the Anti-TNF Therapy in Latin American Crohn's Disease Patients. Digestion 91:2, pages 158-163.
Crossref
Crossref
Maria K. Magnusson, Hans Strid, Stefan Isaksson, Antal Bajor, Anders Lasson, Kjell-Arne Ung & Lena ?hman. (2015) Response to Infliximab Therapy in Ulcerative Colitis is Associated With Decreased Monocyte Activation, Reduced CCL2 Expression and Downregulation of Tenascin C. Journal of Crohn's and Colitis 9:1, pages 56-65.
Crossref
Crossref
Barrett G. Levesque, William J. Sandborn, Joannie Ruel, Brian G. Feagan, Bruce E. Sands & Jean-Frederic Colombel. (2015) Converging Goals of Treatment of Inflammatory Bowel Disease From Clinical Trials and Practice. Gastroenterology 148:1, pages 37-51.e1.
Crossref
Crossref
Mark A. Samaan & Geert D’Haens. 2015. Endoscopy in Inflammatory Bowel Disease. Endoscopy in Inflammatory Bowel Disease
205
226
.
R.V. Bryant, S. Winer, Travis SPL & R.H. Riddell. (2014) Systematic review: Histological remission in inflammatory bowel disease. Is ‘complete’ remission the new treatment paradigm? An IOIBD initiative. Journal of Crohn's and Colitis 8:12, pages 1582-1597.
Crossref
Crossref
Amirkaveh Mojtahed, Reena Khanna, William J. Sandborn, Geert R. DʼHaens, Brian G. Feagan, Lisa M. Shackelton, Kenneth A. Baker, Elena Dubcenco, Mark A. Valasek, Karel Geboes & Barrett G. Levesque. (2014) Assessment of Histologic Disease Activity in Crohnʼs Disease. Inflammatory Bowel Diseases 20:11, pages 2092-2103.
Crossref
Crossref
Reena Khanna, Guillaume Bouguen, Brian G. Feagan, Geert DʼHaens, William J. Sandborn, Elena Dubcenco, K. Adam Baker & Barrett G. Levesque. (2014) A Systematic Review of Measurement of Endoscopic Disease Activity and Mucosal Healing in Crohnʼs Disease. Inflammatory Bowel Diseases 20:10, pages 1850-1861.
Crossref
Crossref
David F. Schaeffer, Joanna C. Walsh, Richard Kirsch, Matti Waterman, Mark S. Silverberg & Robert H. Riddell. (2014) Distinctive histopathologic phenotype in resection specimens from patients with Crohn’s disease receiving anti–TNF-α therapy. Human Pathology 45:9, pages 1928-1935.
Crossref
Crossref
Alan C. Moss. (2014) The meaning of low-grade inflammation in clinically quiescent inflammatory bowel disease. Current Opinion in Gastroenterology 30:4, pages 365-369.
Crossref
Crossref
Magali de Bruyn, Ingrid Arijs, Willem-Jan Wollants, Kathleen Machiels, Kristel Van Steen, Gert Van Assche, Marc Ferrante, Paul Rutgeerts, S?verine Vermeire & Ghislain Opdenakker. (2014) Neutrophil Gelatinase B?associated Lipocalin and Matrix Metalloproteinase-9 Complex as a Surrogate Serum Marker of Mucosal Healing in Ulcerative Colitis. Inflammatory Bowel Diseases 20:7, pages 1198-1207.
Crossref
Crossref
Antonio Tursi, Walter Elisei, Marcello Picchio, Antonio Penna, Piera Giuseppina Lecca, Giacomo Forti, GianMarco Giorgetti, Roberto Faggiani, Costantino Zampaletta, Giorgio Pelecca & Giovanni Brandimarte. (2014) Effectiveness and safety of infliximab and adalimumab for ambulatory Crohn's disease patients in primary gastroenterology centres. European Journal of Internal Medicine 25:5, pages 485-490.
Crossref
Crossref
Jean–Frédéric Colombel, Paul J. Rutgeerts, William J. Sandborn, Mei Yang, Anne Camez, Paul F. Pollack, Roopal B. Thakkar, Anne M. Robinson, Naijun Chen, Parvez M. Mulani & Jingdong Chao. (2014) Adalimumab Induces Deep Remission in Patients With Crohn's Disease. Clinical Gastroenterology and Hepatology 12:3, pages 414-422.e5.
Crossref
Crossref
Magali de Bruyn, Kathleen Machiels, Jennifer Vandooren, Bart Lemmens, Leentje Van Lommel, Christine Breynaert, Jan Van der Goten, Dominiek Staelens, Thomas Billiet, Gert De Hertogh, Marc Ferrante, Gert Van Assche, Séverine Vermeire, Ghislain Opdenakker, Frans Schuit, Paul Rutgeerts & Ingrid Arijs. (2014) Infliximab Restores the Dysfunctional Matrix Remodeling Protein and Growth Factor Gene Expression in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 20:2, pages 339-352.
Crossref
Crossref
Jingtao Chen. (2014) MESALAMINE-INDUCED NEPHROTOXICITY IN THE TREATMENT OF CROHN DISEASE. Gastroenterology Nursing 37:1, pages 70-73.
Crossref
Crossref
Karel Geboes. 2014. Colitis. Colitis
191
196
.
Claudio Papi, Federica Fascì-Spurio, Francesca Rogai, Alessia Settesoldi, Giovanna Margagnoni & Vito Annese. (2013) Mucosal healing in inflammatory bowel disease: Treatment efficacy and predictive factors. Digestive and Liver Disease 45:12, pages 978-985.
Crossref
Crossref
Atsushi Sakuraba, Maria L. Annunziata, Russell D. Cohen, Stephen B. Hanauer & David T. Rubin. (2013) Mucosal Healing Is Associated with Improved Long-term Outcome of Maintenance Therapy with Natalizumab in Crohn?s Disease. Inflammatory Bowel Diseases 19:12, pages 2577-2583.
Crossref
Crossref
Peter De Cruz, Michael A. Kamm, Lani Prideaux, Patrick B. Allen & Greg Moore. (2013) Mucosal Healing in Crohnʼs Disease. Inflammatory Bowel Diseases 19:2, pages 429-444.
Crossref
Crossref
Karel Geboes. 2013. Morson and Dawson's Gastrointestinal Pathology. Morson and Dawson's Gastrointestinal Pathology
315
372
.
Jakob Benedict Seidelin, Mehmet Coskun & Ole Haagen Nielsen. 2013.
101
123
.
Florian Rieder, Thomas Karrasch, Shomron Ben-Horin, Anja Schirbel, Robert Ehehalt, Jan Wehkamp, Colin de Haar, Dominique Velin, Giovanni Latella, Franco Scaldaferri, Gerhard Rogler, Peter Higgins & Miquel Sans. (2012) Results of the 2nd Scientific Workshop of the ECCO (III): Basic mechanisms of intestinal healing. Journal of Crohn's and Colitis 6:3, pages 373-375.
Crossref
Crossref
Anne Christine W. Vos & Daniel W. Hommes. 2012. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis
535
547
.
Rachele Ciccocioppo, Catherine Klersy, Maria Luisa Russo, Monica Valli, Vincenzo Boccaccio, Venerina Imbesi, Sandro Ardizzone, Gabriele Bianchi Porro & Gino Roberto Corazza. (2011) Validation of the Italian translation of the Inflammatory Bowel Disease Questionnaire. Digestive and Liver Disease 43:7, pages 535-541.
Crossref
Crossref
Taina Sipponen, Hannu Nuutinen, Ulla Turunen & Martti Färkkilä. (2010) Endoscopic evaluation of Crohnʼs disease activity. Inflammatory Bowel Diseases 16:12, pages 2131-2136.
Crossref
Crossref
Mi Jin KimYon Ho Choe. (2010) Change in the treatment strategy for pediatric Crohn's disease. Korean Journal of Pediatrics 53:9, pages 830.
Crossref
Crossref
Guillaume Pineton de Chambrun, Laurent Peyrin-Biroulet, Marc Lémann & Jean-Frédéric Colombel. (2009) Clinical implications of mucosal healing for the management of IBD. Nature Reviews Gastroenterology & Hepatology 7:1, pages 15-29.
Crossref
Crossref
F. A. Frizelle, A. Ing, R. B. Gearry, M. Whitehead, I. G. Faragher & B. Dobbs. (2009) Immunomodulation does not alter histology in resected Crohn’s disease. Techniques in Coloproctology 13:4, pages 295-300.
Crossref
Crossref
Antonio Di Sabatino, Ulpu Saarialho-Kere, Mark G. Buckley, John N. Gordon, Paolo Biancheri, Laura Rovedatti, Gino R. Corazza, Thomas T. MacDonald & Sylvia L.F. Pender. (2009) Stromelysin-1 and macrophage metalloelastase expression in the intestinal mucosa of Crohn's disease patients treated with infliximab. European Journal of Gastroenterology & Hepatology 21:9, pages 1049-1055.
Crossref
Crossref
Scott Pentiuk, Phillip E Putnam, Margaret H Collins & Marc E Rothenberg. (2009) Dissociation Between Symptoms and Histological Severity in Pediatric Eosinophilic Esophagitis. Journal of Pediatric Gastroenterology & Nutrition 48:2, pages 152-160.
Crossref
Crossref
Gary R Lichtenstein, Stephen B Hanauer & William J Sandborn. (2009) Management of Crohn's Disease in Adults. The American Journal of Gastroenterology 104:2, pages 465-483.
Crossref
Crossref
T. SIPPONEN, P. KÄRKKÄINEN, E. SAVILAHTI, K.-L. KOLHO, H. NUUTINEN, U. TURUNEN & M. FÄRKKILÄ. (2008) Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn’s disease and histological findings. Alimentary Pharmacology & Therapeutics 28:10, pages 1221-1229.
Crossref
Crossref
Taina Sipponen, Erkki Savilahti, Päivi Kärkkäinen, Kaija-Leena Kolho, Hannu Nuutinen, Ulla Turunen & Martti Färkkilä. (2008) Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohnʼs disease. Inflammatory Bowel Diseases 14:10, pages 1392-1398.
Crossref
Crossref
Eyal Gal, Alex Geller, Gerald Fraser, Zohar Levi & Yaron Niv. (2007) Assessment and Validation of the New Capsule Endoscopy Crohn’s Disease Activity Index (CECDAI). Digestive Diseases and Sciences 53:7, pages 1933-1937.
Crossref
Crossref
Brian W Behm & Stephen J Bickston. (2008) Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Taina Sipponen, Erkki Savilahti, Kaija-Leena Kolho, Hannu Nuutinen, Ulla Turunen & Martti Färkkilä. (2008) Crohnʼs disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohnʼs disease activity index and endoscopic findings. Inflammatory Bowel Diseases 14:1, pages 40-46.
Crossref
Crossref
Antonio Di Sabatino, Sylvia L.F. Pender, Claire L. Jackson, Joanna D. Prothero, John N. Gordon, Lucia Picariello, Laura Rovedatti, Guillermo Docena, Giovanni Monteleone, David S. Rampton, Francesco Tonelli, Gino R. Corazza & Thomas T. MacDonald. (2007) Functional Modulation of Crohn?s Disease Myofibroblasts by Anti-Tumor Necrosis Factor Antibodies. Gastroenterology 133:1, pages 137-149.
Crossref
Crossref
T.J. Borody, S. Bilkey, A.R. Wettstein, S. Leis, G. Pang & S. Tye. (2007) Anti-mycobacterial therapy in Crohn's disease heals mucosa with longitudinal scars. Digestive and Liver Disease 39:5, pages 438-444.
Crossref
Crossref
Annabel Kuek, Brian L Hazleman & Andrew J K Östör. (2007) Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution. Postgraduate Medical Journal 83:978, pages 251-260.
Crossref
Crossref
G. Rogler. 2007. Inflammatory Bowel Disease — Diagnostic and Therapeutic Strategies. Inflammatory Bowel Disease — Diagnostic and Therapeutic Strategies
165
182
.
Elana A. Maser, Renata Villela, Mark S. Silverberg & Gordon R. Greenberg. (2006) Association of Trough Serum Infliximab to Clinical Outcome After Scheduled Maintenance Treatment for Crohn’s Disease. Clinical Gastroenterology and Hepatology 4:10, pages 1248-1254.
Crossref
Crossref
Ismail Sagap & Feza H. Remzi. (2006) Ileal Pouch Anal Anastomosis and Crohn?s Disease. Seminars in Colon and Rectal Surgery 17:2, pages 91-95.
Crossref
Crossref
J.C. Escher. (2006) Nutritional therapy in paediatric Crohn's disease: More food for thought?. Digestive and Liver Disease 38:6, pages 387-388.
Crossref
Crossref
Luca Frulloni, Laura Bernardoni, Chiara Scattolini & Italo Vantini. 2006. Inflammatory Bowel Disease and Familial Adenomatous Polyposis. Inflammatory Bowel Disease and Familial Adenomatous Polyposis
157
170
.